Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06614946 · ClinicalTrials.gov registry record · NA
Improving Coping to Reduce Suicide Risk Following ED Discharge
A NA study, sponsored by University of Michigan.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06614946: Clinical Trial NA study, sponsored by University of Michigan.
NCT06614946 is a NA study that has not yet begun recruiting, run by University of Michigan. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06614946, a NA study, has not yet begun recruiting, sponsored by University of Michigan.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The researchers hope to learn whether an electronic safety plan (ESP) and a supportive text messaging program are feasible and acceptable to adult patients with recent suicidal thoughts or behavior after emergency department (ED) discharge. From this study, the researchers also hope to learn how to best carry out the ESP and text messaging program to improve outcomes for patients after ED discharge.
Interventions
- BEHAVIORAL Electronic Safety Plan (ESP)
- BEHAVIORAL Text support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-02 |
| Phase | NA |
What is known before NCT06614946 opens enrollment
NCT06614946 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Electronic Safety Plan (ESP) is the first listed.
NCT06614946 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06614946 about?
NCT06614946 is a clinical study titled "Improving Coping to Reduce Suicide Risk Following ED Discharge". The researchers hope to learn whether an electronic safety plan (ESP) and a supportive text messaging program are feasible and acceptable to adult patients with recent suicidal thoughts or behavior after emergency department (ED) discharge. From this study, the researchers also hope to learn how to ...
What is the current status of trial NCT06614946?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-05. Estimated completion is 2027-02.
What interventions are being tested in trial NCT06614946?
The interventions under investigation include: Electronic Safety Plan (ESP) (BEHAVIORAL), Text support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06614946?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06614946's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia